Document is current
Any future updates will be listed below
-
Authors
Kal, Satadeepa
Jati, Suborno
Tang, Kechun
Webster, Nicholas J. G. https://orcid.org/0000-0002-3827-5750
Corti, Angelo
Mahata, Sushil K. https://orcid.org/0000-0002-8300-9873
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG078635)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG091126)
Department of Veterans Affairs | Veterans Affairs San Diego Healthcare System (RX004398)
Department of Veterans Affairs | Veterans Affairs San Diego Healthcare System (IBX005224)
- License Information
-
More Information
Article History
Received: 8 January 2026
Revised: 12 April 2026
Accepted: 6 May 2026
First Online: 21 May 2026
Ethics
Ethics approval (animal studies): All procedures involving animals, including care, treatment, and euthanasia, were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of the University of California, San Diego (UCSD) under protocol number S00048M, and were conducted in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals.
Competing interests: SKM is the founder of CgA Therapeuticals, Inc. and co-founders of Siraj Therapeutics. A U.S. provisional patent (No.63/751,092) was filed on January 29, 2025, listing Sushil K. Mahata, Soo Jin Park, and Satadeepa Kal as co-inventors. Rest of the authors declare no conflict of interest.
